↓ Skip to main content

Down‐titration and discontinuation strategies of tumor necrosis factor–blocking agents for rheumatoid arthritis in patients with low disease activity

Overview of attention for article published in Cochrane database of systematic reviews, September 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (86th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

twitter
20 X users

Citations

dimensions_citation
77 Dimensions

Readers on

mendeley
139 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Down‐titration and discontinuation strategies of tumor necrosis factor–blocking agents for rheumatoid arthritis in patients with low disease activity
Published in
Cochrane database of systematic reviews, September 2014
DOI 10.1002/14651858.cd010455.pub2
Pubmed ID
Authors

Noortje van Herwaarden, Alfons A den Broeder, Wilco Jacobs, Aatke van der Maas, Johannes WJ Bijlsma, Ronald F van Vollenhoven, Bart JF van den Bemt

Abstract

Anti-tumor necrosis factor (TNF) agents are effective in treating patients with rheumatoid arthritis (RA), but they are associated with (dose-dependent) adverse effects and high costs. To prevent overtreatment, several trials have assessed the effectiveness of down-titration compared with continuation of the standard dose.

X Demographics

X Demographics

The data shown below were collected from the profiles of 20 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 139 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
United States 1 <1%
Colombia 1 <1%
Sri Lanka 1 <1%
Unknown 135 97%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 25 18%
Researcher 25 18%
Student > Master 18 13%
Student > Bachelor 12 9%
Student > Doctoral Student 11 8%
Other 30 22%
Unknown 18 13%
Readers by discipline Count As %
Medicine and Dentistry 76 55%
Pharmacology, Toxicology and Pharmaceutical Science 10 7%
Nursing and Health Professions 9 6%
Psychology 4 3%
Agricultural and Biological Sciences 3 2%
Other 10 7%
Unknown 27 19%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 April 2018.
All research outputs
#3,216,252
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#5,856
of 11,842 outputs
Outputs of similar age
#34,416
of 264,313 outputs
Outputs of similar age from Cochrane database of systematic reviews
#108
of 225 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,842 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 38.9. This one has gotten more attention than average, scoring higher than 50% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 264,313 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 225 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.